When Cirrhosis Leads to Transplant Evaluation: The Signs That Prompt a Referral

The appointment was supposed to be routine. Then the hepatologist paused over the ultrasound report, noted the new fluid around the liver, and said a sentence that lands differently in every family: “I think it is time we had the transplant program meet you.” The patient had felt tired, not dying. His daughter heard a countdown. Both reactions make sense, and both miss what the referral actually is.

Knowing when cirrhosis needs transplant evaluation is less about a single dramatic moment and more about recognizing a shift in the liver’s story. For years a scarred liver can quietly keep up with the body’s demands. At some point it stops keeping up, and the first visible slip is the signal that specialists have agreed, across guidelines and continents, should trigger a referral.

This explainer walks through those signals, the scoring system behind the decisions, who tends to be listed and who is asked to wait, and the questions worth bringing to the room.

How does cirrhosis progress, and why does decompensation change everything?

Cirrhosis is advanced scarring of the liver, the end stage of years of injury from hepatitis viruses, alcohol, fat-related liver disease, autoimmune conditions or blocked bile ducts. Scar tissue replaces working liver cells and, just as importantly, distorts the plumbing. Blood that should flow freely through the organ meets resistance, and pressure backs up in the portal vein, the large vessel that carries blood from the gut to the liver. Doctors call that backed-up pressure portal hypertension.

For a long stretch, often years, the liver compensates. Its reserve is remarkable: it can lose a large share of healthy tissue and still make clotting proteins, clear toxins and process medicines. This phase is called compensated cirrhosis, and many people in it feel close to normal. Blood tests may be only mildly off. Scans show a nodular, shrunken organ, but life goes on.

Decompensation is the point where that reserve runs out and the consequences become visible. The pressure forces fluid into the abdomen, which is ascites. Blood rerouted around the liver swells veins in the esophagus and stomach into varices that can bleed. Toxins the liver would normally clear, especially ammonia-related compounds, reach the brain and cause hepatic encephalopathy, a reversible confusion that can range from subtle forgetfulness to deep sleepiness. Bilirubin, the yellow pigment from recycled red cells, builds up and tints the skin and eyes.

Why does this one transition matter so much? Because, as MedlinePlus and the NIH’s digestive disease institute both describe, compensated and decompensated cirrhosis behave like two different illnesses. The first is a chronic condition to monitor and treat at its cause. The second is a condition in which the organ itself is failing, and the conversation about replacing it begins.

When cirrhosis needs transplant evaluation: the signs that usually prompt a referral

Ask a transplant hepatologist what triggers a referral and the first answer is almost always the same: the first decompensating event. Not the third hospital stay, not the point where someone cannot climb stairs. The first one. Mayo Clinic and the NHS list the same cluster of complications as the reason cirrhosis moves toward transplant consideration, and they map neatly onto what was described above.

Ascites is often the earliest. A waistband that will not close, ankles that pit when pressed, or a weight gain of several pounds in a week with no change in eating all point to fluid accumulation rather than fat. Variceal bleeding is the most frightening sign: vomiting blood, or passing black, tarry stools, is an emergency in its own right and also a marker that portal pressure has reached a dangerous level. Hepatic encephalopathy can be missed for months, because a spouse may be the only one who notices a reversed sleep pattern, a new vagueness, or handwriting that has changed.

Jaundice that appears without an obvious trigger, such as a new medicine or a gallstone, sits in the same category. So does a sudden drop in kidney function, which in cirrhosis can signal hepatorenal syndrome, a condition where the failing liver disturbs blood flow to otherwise healthy kidneys. An infection of the ascitic fluid itself, called spontaneous bacterial peritonitis, is another event that programs treat as a referral trigger.

Two more signs belong on the list even though they are not classic decompensation. A liver mass that turns out to be hepatocellular carcinoma, the main type of primary liver cancer, prompts referral when it falls within guideline size and number limits. And a steadily rising MELD score on routine blood work, even in someone who still feels well, is enough on its own for many programs to ask for a conversation.

What does the MELD score for transplant actually measure?

MELD stands for Model for End-Stage Liver Disease. It is a number calculated from routine blood tests, and in the United States it is the main tool used to rank how urgently someone on the waiting list needs a liver. Cleveland Clinic describes the scale as running from 6 at the mild end to 40 at the most severe, with higher numbers reflecting a higher short-term risk from liver failure.

Four laboratory values drive it, and each tells a different part of the story. Bilirubin measures how well the liver clears the yellow pigment from old red cells. INR, the international normalized ratio, measures how quickly blood clots, which depends on proteins the liver manufactures. Creatinine reflects kidney function, because kidneys struggle when the liver fails. Sodium, added in the updated version of the score, captures the dilution of body salt that accompanies severe fluid retention.

What MELD does not measure deserves equal attention. It says nothing about how confused someone is, how much fluid they are carrying, how much muscle they have lost, or how often they land in the emergency department. Two people with the same score can have very different daily lives. That is why evaluation teams look at the number alongside the person, and why the score is paired with a separate system of exception points for conditions such as liver cancer that threaten life without raising the four lab values.

One more practical detail: MELD is recalculated. Scores on the list are updated at intervals that depend on how high they are, and a person’s priority rises or falls with their blood work. A single reading is a snapshot. The trend over months, which your hepatologist watches, is what tends to tip a referral decision.

Are there signs you need a liver transplant that the MELD score can miss?

Yes, and transplant programs are frank about it. Several conditions can make a liver effectively unlivable while the four MELD laboratory values sit stubbornly low. Guidelines handle this through exception points, extra priority granted by a review board when the standard score underestimates risk.

Hepatocellular carcinoma is the most common example. Early liver cancer rarely disturbs bilirubin or clotting, so a person could have a dangerous tumor and a reassuring MELD. When the cancer is confined to the liver and falls within the size and number limits that transplant guidelines set, programs typically apply for exception priority, because removing the whole organ treats both the cancer and the cirrhosis beneath it.

Hepatopulmonary syndrome is a less familiar one. Here the liver disease causes tiny blood vessels in the lungs to widen, so blood passes through without picking up enough oxygen. The hallmark is breathlessness that is worse sitting or standing than lying down. Blood tests look ordinary; oxygen levels do not.

Other situations that evaluation teams weigh outside the score include relentless itching from cholestatic diseases such as primary biliary cholangitis, where bile acids accumulate in the skin; repeated infections of the bile ducts in primary sclerosing cholangitis; hepatic encephalopathy that keeps recurring despite treatment; and profound muscle wasting, known as sarcopenia, which signals that the body’s metabolic engine is failing even when numbers look stable.

The honest summary is that the MELD score is an excellent tool for one job, ranking urgency fairly across a waiting list, and a poor tool for another, deciding whether a particular person should be evaluated at all. That second decision belongs to a clinician who knows the whole chart, and it is the reason a referral can be appropriate at a score that sounds unremarkable.

What actually happens during a liver transplant evaluation?

An evaluation is a structured investigation, usually spread over several visits, with one question at its center: would a transplant help this person more than it could harm them, and is now the right time? Johns Hopkins and Mayo Clinic describe the same broad components, and most programs follow a similar pattern.

Blood work comes first and goes well beyond liver function. Teams check blood type, screen for past or current viral infections, assess kidney function and look for clotting or immune problems that could complicate surgery. Imaging follows: an ultrasound or CT or MRI of the liver and its vessels to map anatomy, rule out tumors and confirm that the portal vein is open enough to connect a new organ.

Because a transplant is a long operation with significant blood loss and fluid shifts, the heart and lungs receive close attention. An echocardiogram, a stress test or coronary assessment, and pulmonary function tests are routine. A dental review looks for hidden infection, since the medicines that prevent rejection suppress the immune system afterward. Cancer screening appropriate to age and sex is brought up to date.

Then come the conversations that patients often find most surprising. A social worker and often a psychologist or psychiatrist meet you and your support people to talk about who will drive you to appointments, how medicines will be managed, and, where alcohol or other substances contributed to the liver disease, what recovery support is in place. A dietitian assesses muscle and nutrition. A transplant coordinator explains how the waiting list works and what the call will sound like.

Finally, a multidisciplinary committee reviews everything together. The possible outcomes are three: listing, deferral with a plan to address specific issues, or a decision that transplant is not an appropriate option. Each comes with an explanation, and each can be discussed.

Who is usually listed, and who is usually asked to wait?

Transplant teams think about timing as a balance of two risks: the risk of dying or deteriorating from liver disease without surgery, and the risk of the surgery and lifelong immunosuppression itself. Listing makes sense when the first clearly outweighs the second.

People most often listed are those with decompensated cirrhosis and a rising MELD score, those whose liver cancer meets guideline criteria, those with the MELD-blind complications described earlier, and, in a different pathway, people with sudden acute liver failure. In each case the liver is actively threatening life and no medical treatment can reverse the underlying scarring.

Being asked to wait is common and does not mean rejection. The clearest example is compensated cirrhosis with a low MELD score: the person is unwell enough to be referred, which was the right call, but not yet unwell enough for the operation to offer a net benefit. Programs follow these patients closely and move quickly if the picture changes.

Other reasons to wait are practical and often fixable. An untreated infection needs clearing. A heart or lung problem found during testing may need treatment first. Someone with alcohol-related cirrhosis is typically asked to demonstrate sustained abstinence and engagement with support; the NHS is explicit that continued drinking is a barrier because it would damage the new liver. Severe frailty may prompt a supervised nutrition and exercise plan before listing, because physical reserve shapes recovery. Sometimes a tumor needs further characterization before the committee can decide.

In my view, the most useful mental shift for patients is to see deferral as a to-do list rather than a verdict. Teams write down what would need to change, and many people return to be listed once it has.

What disqualifies you from liver transplant, and what is only a temporary barrier?

This is one of the most searched questions about cirrhosis, and the answer is more nuanced than most lists suggest. Programs distinguish between barriers that cannot be changed and barriers that can. The second group is larger than people expect.

Type of barrier	Examples commonly cited by transplant programs	What usually happens
Generally absolute	Cancer that has spread outside the liver; liver cancer beyond guideline limits; severe, untreatable heart or lung disease that would make surgery unsurvivable; uncontrolled infection throughout the body; ongoing active alcohol or drug use	Transplant is not offered; the team focuses on treating complications and on comfort and quality of life
Relative or modifiable	Recent alcohol use with a short period of abstinence; treatable infection; weight at either extreme affecting surgical safety; poorly controlled diabetes or blood pressure; significant frailty or muscle loss; limited caregiver support	Listing deferred with a specific plan; re-evaluated once addressed
Not a barrier on its own	Older age, alcohol as the original cause, a history of hepatitis B or C, a prior cancer that has been treated and cleared, hepatic encephalopathy	Assessed individually alongside overall fitness

Two clarifications matter. First, age is treated as a question of physiological fitness, not a number on a birth certificate; Mayo Clinic notes that each person is assessed individually. Second, alcohol-related liver disease is one of the most common reasons for transplant worldwide. What programs require is evidence that the drinking has stopped and will stay stopped, usually through a documented period of abstinence and participation in support, not a judgment about the past.

Where a program decides transplant is not an option, that decision can usually be discussed, and a second opinion from another program is a legitimate step that your own team can facilitate.

Why does earlier referral matter more than most people think?

There is a persistent and understandable belief that transplant referral should be saved for the very end, as a last resort when nothing else works. The evidence base points the other way, and most hepatologists would say the timing error they see is referral too late, not too early.

The first reason is pace. Decompensated cirrhosis does not decline on a smooth curve. It moves in steps, with a bleed, an infection or a kidney injury dropping someone from manageable to critically ill within days. If the evaluation has not been done, that crisis can arrive before anyone has checked the heart, mapped the blood vessels or confirmed that the person is a candidate at all. Evaluation itself takes weeks of appointments, and a hospital bed is a poor place to begin it.

The second reason is reserve. Muscle, nutrition and fitness erode as liver disease advances, and they are among the strongest predictors of how someone copes with a long operation. Referral while a person can still walk, eat and build strength gives the team room to protect that reserve. Waiting until frailty is severe can convert a candidate into someone the committee must decline.

The third reason is simpler: an evaluation is not a commitment. Many people who are assessed early are told they are not yet sick enough to list, and that is a good outcome. They leave with a baseline on file, a plan for what would trigger listing, and a relationship with the team that would eventually care for them.

If there is a single opinion worth holding firmly from this article, it is this: the first episode of decompensation is the moment to ask whether a referral has been made, and the question is a reasonable one to put to any doctor managing your cirrhosis.

What do the weeks after a referral usually look like?

Timelines vary between programs and between patients, so what follows is the typical shape rather than a schedule. Your coordinator will give you the specific version.

The first contact is usually an introductory visit with a transplant hepatologist, who reviews your history, confirms the referral is appropriate and explains the process. Testing then unfolds over the following weeks. Some programs compress it into a few intensive days; others spread it across several outpatient visits so that each specialist can see you. People often describe this phase as oddly reassuring: for the first time, every part of the body is being examined with a single purpose.

Once results are in, the committee meets, typically on a fixed weekly or fortnightly cycle. You are told the outcome by your coordinator, usually with a follow-up appointment to discuss it. If you are listed, your blood work is repeated at set intervals so that your MELD score stays current, and you are given clear instructions about staying reachable and arranging transport.

Waiting itself has no reliable typical length. It depends on blood type, body size, MELD score, regional organ availability and whether a living donor is being considered, which is why this article does not quote a figure. What is predictable is the rhythm of monitoring, with regular clinic visits and prompt review after any new complication.

After the operation, the NHS describes a hospital stay of up to around two weeks, with frequent clinic visits and blood tests in the early months to adjust anti-rejection medicine. Mayo Clinic notes that feeling fully recovered commonly takes six months or more. These are typical ranges from published patient guidance, not promises, and individual recovery depends heavily on how unwell someone was going in.

What are the alternatives if transplant is not the right step right now?

A transplant is the only treatment that replaces a scarred liver, but it is far from the only treatment for cirrhosis. For many people, especially those deferred or declined, the alternatives are not consolation prizes; they are the main plan, and they can hold the disease steady for years.

Treating the cause comes first. Antiviral medicines can suppress hepatitis B or clear hepatitis C, and in some people with early decompensation that alone shifts the liver back toward compensation. Complete abstinence from alcohol can do the same in alcohol-related disease; the NHS and MedlinePlus both describe meaningful recovery of function when drinking stops. Weight management and diabetes control address fat-related liver disease.

Complications each have their own management. Fluid retention is treated with diuretic medicines that help the kidneys excrete salt and water, with salt restriction, and, when fluid builds up faster than tablets can manage, with paracentesis, a bedside procedure to drain the abdomen. Varices are managed with a class of blood pressure medicines called non-selective beta blockers, which lower portal pressure, and with endoscopic banding to tie off swollen veins. Hepatic encephalopathy is treated with laxative-type medicines that reduce ammonia absorption from the gut, sometimes alongside an antibiotic that acts within the bowel. Decisions about any of these sit entirely with the prescribing team.

For stubborn fluid or repeated bleeding, specialists may consider a TIPS procedure, a transjugular intrahepatic portosystemic shunt, which places a small tube inside the liver to divert blood and relieve pressure. Liver cancer confined to the organ may be treated with ablation or targeted embolization. Living-donor transplant, in which a healthy person donates part of their liver, widens options in some programs. And palliative care, offered early and in parallel with active treatment, focuses on symptom control and planning rather than on giving up.

What people often get wrong about when cirrhosis needs transplant evaluation

Myths cluster around transplant because the topic is frightening and the details are rarely explained in a clinic visit. A few deserve correcting plainly.

The first is that a referral means surgery is imminent. It does not. Evaluation is a question, and a frequent honest answer is “not yet.” The second is the mirror image: that you must be close to death to be considered. Programs would much rather meet you after a first episode of ascites than in intensive care after a bleed.

A third misconception holds that alcohol-related cirrhosis is never eligible. It is one of the most common indications for transplant worldwide. What is required is sustained abstinence and engagement with support, and teams are experienced in assessing both without judgment. Related to this is the belief that a past cause, such as hepatitis C, rules you out. Cleared or suppressed viral infection is routinely transplanted.

Fourth, people assume age alone disqualifies. Programs assess fitness, heart and lung health and support systems, and many people in their seventies are evaluated and listed. Fifth, a liver cancer diagnosis is taken to mean transplant is off the table, when in fact early cancer within guideline limits is a reason for priority rather than exclusion.

Sixth, feeling well is mistaken for being well. Hepatic encephalopathy in particular hides from the person who has it, and a rising MELD score can precede symptoms by months. Seventh, the MELD score is treated as the whole decision, when it was never designed to answer the question of who should be evaluated.

Finally, many believe that once declined, always declined. Most deferrals come with explicit, achievable conditions, and re-evaluation after they are met is routine. The door is rarely as closed as it feels on the day.

How can you prepare while the evaluation is under way?

Few things in cirrhosis are fully within a patient’s control, which is exactly why the things that are deserve attention. Preparation during evaluation can change what the committee sees and how recovery goes if a transplant follows.

Nutrition is the foundation. A cirrhotic liver cannot store glucose normally, so the body breaks down muscle overnight for fuel. Dietitians working in liver disease commonly recommend protein spread across small, frequent meals and a late evening snack to shorten the overnight fast; your own dietitian will tailor the amounts and advise on salt if you have fluid retention. Old advice to restrict protein for encephalopathy has been superseded, and starving muscle makes the condition worse, not better.

Movement protects the same reserve. Even gentle, regular walking and simple resistance exercises slow muscle loss. Teams can refer you to a physiotherapist, and some programs run structured prehabilitation.

Alcohol must stop completely, whatever the original cause of the cirrhosis, and the same goes for tobacco, which raises surgical and cardiovascular risk. Vaccinations recommended for people with chronic liver disease, including hepatitis A and B where not already immune, influenza and pneumococcal protection, are easier to complete before immunosuppression begins; your team will advise which apply to you.

Keep an up-to-date list of every medicine, supplement and herbal product you take and show it to the team before starting anything new. Several common over-the-counter products and supplements can injure a struggling liver or kidneys, and Harvard Health and the NIH both caution that herbal remedies are a recognized cause of liver damage.

Finally, bring your support people into the process early. The social work assessment is not a test to pass; it is planning for who will drive, who will notice confusion, and who will help manage medicines. Those answers are part of your candidacy.

Questions to ask your care team

Evaluation visits move quickly, and the most useful questions are often the ones that feel too basic to ask. Writing them down beforehand, and asking a companion to take notes, turns an overwhelming appointment into a working conversation.

Start with where you stand. What stage is my cirrhosis, compensated or decompensated, and what specifically prompted this referral? What is my current MELD score, what is driving it, and how has it changed over the past year? Are there complications in my case that the score does not capture?

Then ask about the decision itself. If I am not listed today, what would need to change for that to happen, and how often will you check? If there are barriers, which ones are modifiable, and what support can you offer to address them? Is living donation an option in this program, and what would that involve for a potential donor?

Ask about the alternatives and the plan in the meantime. Which of my complications can be managed medically or with procedures, and what are the warning signs that one of them is getting worse? Should I be seeing a dietitian or physiotherapist now? Which vaccinations should I complete? Are any of my current medicines or supplements a concern?

Cover logistics and support. Who is my point of contact between visits, and how do I reach the team after hours? What should I do and where should I go if I develop a bleed or confusion? Is there a patient group or psychological support connected to the program?

And ask the question people avoid: if transplant is not an option for me, what would good care look like, and can palliative care be involved alongside my hepatology team? A team that answers that openly is one you can trust with the harder decisions ahead.

When to call your doctor

Cirrhosis can change quickly, and several developments should never wait for the next scheduled visit. Some are emergencies that warrant calling emergency services or going straight to an emergency department; others need a same-day call to your hepatology or transplant team.

Seek emergency care immediately if you vomit blood or material that looks like coffee grounds, pass black, tarry or maroon stools, or feel faint or collapse, because these point to bleeding from varices. The same urgency applies to new or worsening confusion, unusual sleepiness that is hard to rouse, or a family member noticing that you are not making sense; hepatic encephalopathy can progress to unconsciousness. Severe abdominal pain with fever in someone who has ascites raises the possibility of spontaneous bacterial peritonitis and needs urgent assessment. Sudden breathlessness or chest pain should be treated as an emergency regardless of cause.

Call your team the same day for a fever without an obvious source, since infection in cirrhosis can escalate fast; for a rapid increase in abdominal girth or a weight gain of several pounds over a few days; for passing much less urine than usual, which may signal kidney strain; for new or deepening yellowing of the skin or eyes; for easy bruising or bleeding from the gums or nose that is new for you; or for persistent vomiting or diarrhea that risks dehydration, which the kidneys of someone with cirrhosis tolerate poorly.

If you are on the waiting list, your coordinator will also want to know about any hospital admission, any new medicine started by another clinician, any infection, and any change in your contact details. Each of these can affect your listing status. When in doubt, call: transplant and hepatology teams would far rather hear about a false alarm than learn afterward about a missed one. Every decision about what happens next rests with the clinicians who know your case.

Frequently asked questions

At what stage of cirrhosis do you need a transplant evaluation?

Referral is usually made at the transition from compensated to decompensated cirrhosis, which is marked by the first episode of ascites, variceal bleeding, hepatic encephalopathy or unexplained jaundice. A steadily rising MELD score, liver cancer within guideline limits, or complications affecting the kidneys or lungs are also triggers. Evaluation at this stage does not mean surgery is imminent; it means the team wants a baseline and a plan before any crisis.

When is a liver transplant indicated for cirrhosis patients rather than just discussed?

Transplant is indicated when the risk from liver disease clearly outweighs the risk of a major operation and lifelong immunosuppression. In practice that means decompensated cirrhosis with a rising MELD score, liver cancer meeting guideline criteria, or complications such as hepatopulmonary syndrome that cannot be managed otherwise. People with compensated disease and low scores are typically monitored rather than listed because surgery would not yet offer a net benefit.

What are the liver transplant evaluation criteria that teams actually use?

Teams assess three broad areas: the severity of liver disease, usually through the MELD score and the pattern of complications; overall fitness for surgery, including heart, lung, kidney and dental health, cancer screening and nutritional status; and psychosocial readiness, covering caregiver support, the ability to manage complex medicines, and sustained abstinence where alcohol or other substances contributed. A multidisciplinary committee weighs all three together before deciding.

What is the MELD score for transplant and why does it change?

The MELD score is a number from 6 to 40, calculated from bilirubin, INR, creatinine and sodium, that estimates short-term risk from liver failure and is used to rank urgency on the waiting list. It changes because those blood values change; worsening liver or kidney function raises it, and improvement lowers it. Listed patients have blood tests repeated at set intervals so their place on the list reflects their current condition.

What disqualifies you from liver transplant permanently?

Generally absolute barriers include cancer that has spread beyond the liver, liver cancer larger or more numerous than guideline limits allow, severe untreatable heart or lung disease, uncontrolled infection throughout the body, and ongoing active alcohol or drug use. Many other issues, such as recent drinking with a short abstinence period, a treatable infection, frailty or limited support, are temporary and lead to deferral with a plan rather than a permanent decision.

Does alcohol-related cirrhosis rule out a liver transplant?

No. Alcohol-related liver disease is one of the most common reasons for liver transplant worldwide. Programs require evidence that drinking has stopped and will stay stopped, typically a documented period of abstinence and engagement with counseling or support services, because continued drinking would damage the new liver. The assessment focuses on current behavior and future risk, not on judgment about the past.

Can you be too old for a liver transplant?

There is no universal age cutoff. Transplant programs assess physiological fitness, including heart and lung function, kidney health, muscle strength and support at home, rather than age alone, and people in their seventies are evaluated and listed. Older age does raise surgical risk and is weighed alongside everything else, which is why the committee reviews each person individually rather than applying a number.

What are the signs you need a liver transplant that are easy to miss?

Hepatic encephalopathy is the most commonly missed, because the person affected often does not notice the subtle confusion, reversed sleep pattern or personality change that family members see. Breathlessness that is worse upright than lying down can signal hepatopulmonary syndrome. A rising MELD score on routine blood work can precede any symptoms by months. None of these should be used for self-diagnosis; they are reasons to ask your hepatologist whether referral is appropriate.

Does being referred for evaluation mean I will definitely have surgery?

No. An evaluation has three possible outcomes: listing for transplant, deferral with specific conditions to address, or a decision that transplant is not an appropriate option. Many people evaluated early are told they are not yet sick enough to list, which is a good outcome, and they leave with a baseline on file and a clear plan for what would trigger listing in the future.

What happens if I am listed but then get better?

Improvement is recognized and acted on. If the cause of cirrhosis is treated, for example through sustained alcohol abstinence or antiviral therapy for hepatitis, some people recompensate and their MELD score falls. The team may then make the listing inactive or remove it while continuing close monitoring, and relisting is possible if the disease progresses again. Listing is a dynamic status that follows your current condition, not a one-way commitment.

References

• NHS: Liver transplant
• NIH NIDDK: Cirrhosis
• MedlinePlus: Cirrhosis

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.